Blogs & News

In a groundbreaking study published in Cell, researchers from the University of Cambridge and Baylor College of Medicine have uncovered a pivotal gene, TRPC5, implicated in severe obesity, behavioral disorders, and postnatal depression. This discovery not only sheds light on the genetic underpinnings of these conditions but also suggests a potential therapeutic avenue involving oxytocin, commonly known as the 'love hormone'.

Obesity and postnatal depression represent significant public health challenges globally. Postnatal depression affects a substantial number of women worldwide, with severe consequences including heightened suicide risk. Concurrently, obesity rates have surged dramatically across all age groups over recent decades. These issues underscore the urgent need for deeper biological insights and innovative treatment strategies.

The research began with an investigation into two boys afflicted by severe obesity, anxiety, autism spectrum traits, and hypersensitivity triggered by sensory stimuli. Both boys were found to lack a functional TRPC5 gene, located on the X chromosome. Remarkably, their mothers, who also lacked this gene, exhibited obesity and had experienced postnatal depression.

To validate the gene's role, researchers turned to mouse models engineered with a defective Trpc5 gene. Male mice exhibited weight gain, anxiety, and social aversion, mirroring the human phenotype. Female mice, particularly after becoming mothers, displayed depressive behaviors and impaired maternal care, highlighting a gender-specific manifestation of TRPC5 deficiency.

Dr. Yong Xu, from Baylor College of Medicine, emphasized the striking parallels observed in mice lacking the TRPC5 gene, including depressive symptoms and maternal difficulties. These findings underscored the gene's critical role in shaping complex behaviors.

TRPC5 belongs to a gene family crucial for sensory signal detection. Specifically, it modulates pathways in the hypothalamus, a brain region pivotal for appetite regulation. Further investigation revealed that TRPC5 influences oxytocin-producing neurons in the hypothalamus, linking it to fundamental behaviors like social bonding and emotional regulation.

Deleting TRPC5 from oxytocin neurons in mice led to behaviors resembling anxiety, overeating, and impaired sociability. Intriguingly, restoring TRPC5 function alleviated these symptoms, suggesting a potential therapeutic target.

Additionally, TRPC5 interacts with POMC neurons, known regulators of appetite and weight. Dysfunction in these neurons due to genetic mutations often leads to early-onset obesity. The combined effects on both oxytocin and POMC pathways highlight TRPC5's intricate role in biological regulation.

Professor Sadaf Farooqi, from the University of Cambridge, underscored the broader implications of their findings. She noted that understanding TRPC5 deficiency provides critical insights into instinctual behaviors controlled by the hypothalamus, crucial for survival and well-being.

While TRPC5 gene deletions are rare, analysis of large genetic databases identified variants associated with higher body mass index in hundreds of individuals. This suggests broader implications for understanding obesity susceptibility in the general population.

The study's findings propose oxytocin as a potential treatment for individuals with TRPC5 deficiencies and mothers experiencing postnatal depression. Oxytocin's role in depression and maternal care has been explored in animal studies and small-scale trials, paving the way for larger clinical investigations.

Professor Farooqi emphasized the biological basis of behaviors often perceived as purely psychological, urging a more compassionate approach towards individuals grappling with conditions like obesity and depression. The research was supported by Wellcome, NIHR, and other foundations, highlighting its collaborative and interdisciplinary nature.